An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation

by Karina Krotova, Andrew Day, George Aslanidi
Published 2019-12-01

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors

by Chen Ling, Zifei Yin, Jun Li, Daniel Zhang, George Aslanidi, Arun Srivastava
Published 2016-01-01

Salivary PYY: a putative bypass to satiety.

by Andres Acosta, Maria D Hurtado, Oleg Gorbatyuk, Michael La Sala, David Duncan, George Aslanidi, Martha Campbell-Thompson, Lei Zhang, Herbert Herzog, Antonis Voutetakis, Bruce J Baum, Sergei Zolotukhin
Published 2011-01-01

An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy

by Gregg A. Duncan, Namho Kim, Yanerys Colon-Cortes, Jason Rodriguez, Marina Mazur, Susan E. Birket, Steven M. Rowe, Natalie E. West, Alessandra Livraghi-Butrico, Richard C. Boucher, Justin Hanes, George Aslanidi, Jung Soo Suk
Published 2018-06-01